Correlation between patient-reported fatigue and hemoglobin (Hgb) levels in metastatic renal cell carcinoma (mRCC) patients (pts) receiving sunitinib (SU).

被引：0
|
作者：
Davis, Mellar P.
Matczak, Ewa M.
Chen, Connie
Korytowsky, Beata
Bhattacharyya, Helen
Lin, Xun
Rini, Brian I.
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Pfizer Oncol, New York, NY USA
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Oncol, Global Hlth Econ Outcomes Res, New York, NY USA
[5] Pfizer Inc, Stat, New York, NY USA
[6] Pfizer Oncol, San Diego, CA USA
[7] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.418
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
418
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Characterizing fatigue associated with sunitinib (SU) in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Cella, David
    Davis, Mellar P.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Hahn, Elizabeth A.
    Korytowsky, Beata
    Bhattacharyya, Helen
    Sandin, Rickard
    Beaumont, Jennifer L.
    Matczak, Ewa
    Motzer, Robert John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Berger, Raanan
    Carducci, Michael Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Roubinov, Keren
    Berger, Raanan
    Carducci, Michael Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [4] CARDIOTOXICITY IN METASTATIC RENAL CELL CARCINOMA (mRCC) PATIENTS TREATED WITH SUNITINIB (SU)
    Ballatore, Valentina
    Prati, Veronica
    Ruatta, Fiorella
    Galizia, Danilo
    Grignani, Giovanni
    Aglietta, Massimo
    Ortega, Cinzia
    [J]. ANTICANCER RESEARCH, 2012, 32 (05) : 1876 - 1877
  • [5] WBC changes as a pharmacodynamic marker of outcome in metastatic renal cell carcinoma (mRCC) patients (Pts) receiving sunitinib
    George, S.
    Richmond, A.
    Elson, P.
    Jin, T.
    Wood, L.
    Garcia, J. A.
    Rini, B. I.
    Finke, J.
    Bukowski, R. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] FATIGUE IN METASTATIC RENAL CELL CARCINOMA (mRCC): CLINICIAN-REPORTED VS. PATIENT-REPORTED OUTCOME
    Rizzo, Mimma
    Carteni, Giacomo
    [J]. ANTICANCER RESEARCH, 2013, 33 (05) : 2337 - 2338
  • [7] Outcome of octogenarian versus (vs) young patients (pts) with metastatic renal cell carcinoma (mRCC), treated with sunitinib (su).
    Kushnir, Igal
    Rosenbaum, Eli
    Sarid, David Leonid
    Sella, Avishay
    Gottfried, Maya
    Maimon, Natalie
    Peer, Avivit
    Neumann, Avivit
    Neiman, Victoria
    Kovel, Svetlana
    Gez, Eliahu
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Hammers, Hans J.
    Sinibaldi, Victoria J.
    Berger, Raanan
    Keizman, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Outcome of octogenarian versus (vs) young patients (pts) with metastatic renal cell carcinoma (mRCC), treated with sunitinib (su).
    Kushnir, Igal
    Rosenbaum, Eli
    Sella, Avishay
    Sarid, David
    Gottfried, Maya
    Maimon, Natalie
    Peer, Avivit
    Neumann, Avivit
    Neiman, Victoria
    Kovel, Svetlana
    Gez, Eliahu
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Hammers, Hans J.
    Sinibaldi, Victoria J.
    Berger, Raanan
    Keizman, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [9] Utility values among patients (pts) with metastatic renal cell carcinoma (mRCC) receiving first-line treatment with pazopanib (PZ) and sunitinib (SU).
    Hagiwara, May
    Park, Jinhee
    Delea, Thomas E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Metformin (met) use and outcome of sunitinib (Su) treatment (tx) in diabetic patients (pts) with metastatic renal cell carcinoma (mRCC)
    Keizman, Daniel
    Ish-Shalom, Maya
    Peer, Avivit
    Chish, Adi
    Sella, Avishay
    Gottfried, Maya
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Neiman, Victoria
    Rosenbaum, Eli
    Sarid, David
    Gez, Eliahu
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Weitzen, Rony
    Weitzen, Rony
    Berger, Raanan
    Carducci, Michael Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345